Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00350051
First received: July 7, 2006
Last updated: December 2, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Publications: